296 related articles for article (PubMed ID: 31595157)
1. Cathelicidin-related antimicrobial peptide protects against cardiac fibrosis in diabetic mice heart by regulating endothelial-mesenchymal transition.
Zheng X; Peng M; Li Y; Wang X; Lu W; Wang X; Shan Y; Li R; Gao L; Qiu C
Int J Biol Sci; 2019; 15(11):2393-2407. PubMed ID: 31595157
[No Abstract] [Full Text] [Related]
2. MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart.
Liang C; Gao L; Liu Y; Liu Y; Yao R; Li Y; Xiao L; Wu L; Du B; Huang Z; Zhang Y
Life Sci; 2019 May; 224():12-22. PubMed ID: 30872181
[TBL] [Abstract][Full Text] [Related]
3. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity.
Yan F; Zhang GH; Feng M; Zhang W; Zhang JN; Dong WQ; Zhang C; Zhang Y; Chen L; Zhang MX
Mol Med; 2015 Feb; 21(1):15-25. PubMed ID: 25715248
[TBL] [Abstract][Full Text] [Related]
5. miR-200b Mediates Endothelial-to-Mesenchymal Transition in Diabetic Cardiomyopathy.
Feng B; Cao Y; Chen S; Chu X; Chu Y; Chakrabarti S
Diabetes; 2016 Mar; 65(3):768-79. PubMed ID: 26718496
[TBL] [Abstract][Full Text] [Related]
6. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
[No Abstract] [Full Text] [Related]
7. Saikosaponin A Protects From Pressure Overload-Induced Cardiac Fibrosis via Inhibiting Fibroblast Activation or Endothelial Cell EndMT.
Liu Y; Gao L; Zhao X; Guo S; Liu Y; Li R; Liang C; Li L; Dong J; Li L; Yang H
Int J Biol Sci; 2018; 14(13):1923-1934. PubMed ID: 30443195
[TBL] [Abstract][Full Text] [Related]
8. miR-222 inhibits cardiac fibrosis in diabetic mice heart via regulating Wnt/β-catenin-mediated endothelium to mesenchymal transition.
Wang Z; Wang Z; Gao L; Xiao L; Yao R; Du B; Li Y; Wu L; Liang C; Huang Z; Li P; Zhang Y
J Cell Physiol; 2020 Mar; 235(3):2149-2160. PubMed ID: 31389030
[TBL] [Abstract][Full Text] [Related]
9. A cathelicidin-related antimicrobial peptide suppresses cardiac hypertrophy induced by pressure overload by regulating IGFR1/PI3K/AKT and TLR9/AMPKα.
Wang X; Chen L; Zhao X; Xiao L; Yi S; Kong Y; Jiang Y; Zhang J
Cell Death Dis; 2020 Feb; 11(2):96. PubMed ID: 32029708
[TBL] [Abstract][Full Text] [Related]
10. Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy.
Liu X; Mujahid H; Rong B; Lu QH; Zhang W; Li P; Li N; Liang ES; Wang Q; Tang DQ; Li NL; Ji XP; Chen YG; Zhao YX; Zhang MX
J Cell Mol Med; 2018 Feb; 22(2):808-822. PubMed ID: 29063670
[TBL] [Abstract][Full Text] [Related]
11. Protective Effects of Eicosapentaenoic Acid on the Glomerular Endothelium via Inhibition of EndMT in Diabetes.
Yasuzawa T; Nakamura T; Ueshima S; Mima A
J Diabetes Res; 2021; 2021():2182225. PubMed ID: 34977254
[TBL] [Abstract][Full Text] [Related]
12. Tectorigenin protects against cardiac fibrosis in diabetic mice heart via activating the adiponectin receptor 1-mediated AMPK pathway.
Ma YL; Xu M; Cen XF; Qiu HL; Guo YY; Tang QZ
Biomed Pharmacother; 2024 May; 174():116589. PubMed ID: 38636400
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell metabolic memory causes cardiovascular dysfunction in diabetes.
Yao Y; Song Q; Hu C; Da X; Yu Y; He Z; Xu C; Chen Q; Wang QK
Cardiovasc Res; 2022 Jan; 118(1):196-211. PubMed ID: 33483741
[TBL] [Abstract][Full Text] [Related]
14. Mangiferin alleviates diabetic pulmonary fibrosis in mice via inhibiting endothelial-mesenchymal transition through AMPK/FoxO3/SIRT3 axis.
Fu TL; Li GR; Li DH; He RY; Liu BH; Xiong R; Xu CZ; Lu ZL; Song CK; Qiu HL; Wang WJ; Zou SS; Yi K; Li N; Geng Q
Acta Pharmacol Sin; 2024 May; 45(5):1002-1018. PubMed ID: 38225395
[TBL] [Abstract][Full Text] [Related]
15. The Interaction of Apelin and FGFR1 Ameliorated the Kidney Fibrosis through Suppression of TGF
Gao R; Wu Y; Yang Q; Chen L; Chen J; Wang B; Liu Z; Jin J; Li J; Wu G
Oxid Med Cell Longev; 2023; 2023():5012474. PubMed ID: 36785790
[TBL] [Abstract][Full Text] [Related]
16. MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway.
Geng H; Guan J
Biochem Biophys Res Commun; 2017 Sep; 491(2):329-336. PubMed ID: 28733035
[TBL] [Abstract][Full Text] [Related]
17. Endothelial FGFR1 (Fibroblast Growth Factor Receptor 1) Deficiency Contributes Differential Fibrogenic Effects in Kidney and Heart of Diabetic Mice.
Li J; Liu H; Srivastava SP; Hu Q; Gao R; Li S; Kitada M; Wu G; Koya D; Kanasaki K
Hypertension; 2020 Dec; 76(6):1935-1944. PubMed ID: 33131311
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of endothelial-to-mesenchymal transition in cardiac fibrosis: role of myocardin-related transcription factor A and activating transcription factor 3.
Sharma V; Dogra N; Saikia UN; Khullar M
Can J Physiol Pharmacol; 2017 Oct; 95(10):1263-1270. PubMed ID: 28686848
[TBL] [Abstract][Full Text] [Related]
19. Losartan inhibits endothelial-to-mesenchymal transformation in mitral valve endothelial cells by blocking transforming growth factor-β-induced phosphorylation of ERK.
Wylie-Sears J; Levine RA; Bischoff J
Biochem Biophys Res Commun; 2014 Apr; 446(4):870-5. PubMed ID: 24632204
[TBL] [Abstract][Full Text] [Related]
20. NLRC5 deficiency ameliorates cardiac fibrosis in diabetic cardiomyopathy by regulating EndMT through Smad2/3 signaling pathway.
Wang B; Wu Y; Ge Z; Zhang X; Yan Y; Xie Y
Biochem Biophys Res Commun; 2020 Jul; 528(3):545-553. PubMed ID: 32505342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
